Diabetic retinopathy: current understanding, mechanisms, and treatment strategiesElia J. Duh, Alan W. Stitt|JCI Insight|2017Cited by 1k
The AGE Inhibitor Pyridoxamine Inhibits Development of Retinopathy in Experimental DiabetesAlan W. Stitt, Suzanne R. Thorpe, Cliona Boyle et al.|Diabetes|2002Cited by 356
Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE)Hongliang Zong, Alan W. Stitt|Diabetologia|2010Cited by 199
Myeloid Angiogenic Cells Act as Alternative M2 Macrophages and Modulate Angiogenesis through Interleukin-8Reinhold J. Medina, Alan W. Stitt|Molecular Medicine|2011Cited by 181
Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factorAlan W. Stitt, Tom A. Gardiner|Diabetologia|2004Cited by 61